HomeSearchPaper Details

Long COVID: major findings, mechanisms and recommendations

Hannah Davis, Lisa McCorkell, Julia Moore Vogel, Eric J. Topol

Nature Portfolio (2023) • Volume 21, Issue 3, Pages 133-146

SynthesisNarrativeReviewPDF AvailableGrade Eligible

Overall Assessment

Limited Methodological Quality

Assessment created by PaperScores Medical AI v0.1.0 on Dec 14, 2025

D
49/100

Key Takeaways

  • Long COVID is multisystemic with immune dysregulation, possible viral persistence, vascular issues, and neuroinflammation.
  • Substantial overlap with ME/CFS and dysautonomia; many develop lifelong disability.
  • Diagnostics are nascent; biomarkers and imaging targets emerging (e.g., microclots, small fibre neuropathy).
  • Treatments remain symptomatic/experimental; robust RCTs urgently needed across leading mechanisms.
  • Vaccination reduces risk partially; reinfections add cumulative risk; children also affected.

Conclusion

A thorough, policy-facing synthesis highlighting mechanistic leads and the urgent need for adequately powered, inclusive clinical trials.

Quick Actions

Read Full Paper

Quality Dimensions

Integrity & Transparency

Premise

Literature Positioning

Study Provenance

Methodological Assessment

Study Overview

Publication Details

External Resources

Disclaimer: This assessment is generated by AI and should not be the sole basis for clinical or research decisions. Always review the original paper and consult with domain experts.


Suggested Papers